Northeast Financial Consultants Inc Becton Dickinson & CO Transaction History

Northeast Financial Consultants Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $11,147 - $12,827	48 Added 6.0%	848 $206,000
Q2 2023 Aug 08, 2023	BUY	$238.39 - $265.32 $190,712 - $212,256	800 New	800 $211,000
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $174,632 - $205,528	800 New	800 $203,000
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $187,792 - $220,336	-800 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$230.08 - $250.94 $184,064 - $200,752	800 New	800 $201,000
Q1 2021 May 13, 2021	SELL	$232.09 - $256.88 $185,672 - $205,504	-800 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $177,536 - $196,752	800 New	800 $200,000
Q1 2020 May 13, 2020	SELL	$195.69 - $279.01 $156,552 - $223,208	-800 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $14,187 - $16,009	-60 Reduced 6.98%	800 $218,000
Q3 2019 Nov 13, 2019	BUY	$230.58 - $256.08 $13,834 - $15,364	60 Added 7.5%	860 $218,000
Q1 2019 May 14, 2019	BUY	$206.05 - $248.17 $164,840 - $198,536	800 New	800 $200,000
Q4 2018 Feb 12, 2019	SELL	$204.73 - $257.93 $163,784 - $206,344	-800 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$233.07 - $256.0 $186,456 - $204,800	800 New	800 $208,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

Stay updated on Northeast Financial Consultants Inc with notifications on news.